Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals ; volume:15 ; number:1 ; day:14 ; month:3 ; year:2017 ; pages:1-10 ; date:12.2017
BMC medicine ; 15, Heft 1 (14.3.2017), 1-10, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
- Contributor
- DOI
-
10.1186/s12916-017-0815-7
- URN
-
urn:nbn:de:1111-201703183520
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Baumert, Thomas
- Jühling, Frank
- Ono, Atsushi
- Hoshida, Yujin
- SpringerLink (Online service)
Other Objects (12)
Viral hepatitis and hepatocellular carcinoma
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Hepatitis C virus to hepatocellular carcinoma
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
Plant-derived antivirals against hepatitis c virus infection
Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals
Promotion of hepatocellular carcinoma by hepatitis C virus
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
Viral hepatitis and hepatocellular carcinoma
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Hepatitis C virus to hepatocellular carcinoma
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
Plant-derived antivirals against hepatitis c virus infection
Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals
Promotion of hepatocellular carcinoma by hepatitis C virus
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
Viral hepatitis and hepatocellular carcinoma
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Hepatitis C virus to hepatocellular carcinoma
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
Plant-derived antivirals against hepatitis c virus infection
Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals
Promotion of hepatocellular carcinoma by hepatitis C virus